Percheron Therapeutics (AU:PER) has released an update.
Percheron Therapeutics Limited announced a change in the shareholding of its director, James Garner, who has acquired an additional 375,000 ordinary shares through participation in the company’s Share Purchase Plan. This acquisition raises Garner’s total holding to 1,375,000 shares, reflecting continued confidence in the company’s prospects.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Tesla Stock
- ‘Breath of Fresh Air,’ Says Daniel Ives About Rivian Stock
- ‘It’s Not Too Late to Load Up,’ Says Analyst About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
